Harness the power of the microbiome with Diversigen.
Diversigen provides comprehensive microbiome/metagenomics services to help the pharmaceutical/health industries harness the power of the microbiome. Experienced in gastrointestinal disease states: Irritable Bowel Syndrome, Clostridium Difficile Infection, Ulcerative Colitis, Norovirus, and more.
Custom study design, complex data analysis - all building on research conducted at the Alkek Center for Metagenomics and Microbiome Research at Baylor College of Medicine.
Platform agnostic, flexible sequencing, bioinformatics, handles difficult sample types.